跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,968 条关于
“Hansoh Pharmaceuticals”
全部
8,968
临床试验
548
药物
1,725
机构
2,056
资讯
4,639
去年
Regeneron Licenses Chinese GLP-1/GIP Dual Agonist in $2 Billion Obesity Deal with Hansoh Pharma
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
8个月前
Hansoh Pharmaceutical's Aumolertinib Receives EU Approval for Advanced NSCLC Treatment
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for ES-SCLC
去年
Hansoh Pharma's HS-20093 Receives Breakthrough Therapy Designation in China for Small Cell Lung Cancer
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
11个月前
China's NMPA Accepts Hansoh Pharmaceutical's RET Inhibitor Application for Lung Cancer Treatment
2年前
GSK Licenses Hansoh Pharma's B7-H3 ADC, HS-20093, for $185 Million Upfront
4个月前
Hansoh Biotech Presents Novel Bispecific Antibody and ADC Research at AACR 2026
去年
Hansoh Pharmaceutical Says NMPA Granted Drug Registration Approval Of Third Indication ...
第 1 页,共 464 页
上一页
下一页